China Sky One Listed On NASDAQ, Recognized By Chinese Government For Innovation With Prestigious Award
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China Sky One Medical has succeeded in having its shares listed on the NASDAQ Global Select Market in a move that Sky's CEO said demonstrates the company's solid financial performance over the past three years and strong future outlook
You may also be interested in...
China Sky One Obtains CE Marks As It Sets Its Sights On International Markets
SHANGHAI - NASDAQ-listed China Sky One Medical has received European Union CE Mark status for its Myocardial Infarction and Urine Microalbumin diagnostic test kits. Meeting the EU health and safety standards of products ensures the company can expand to international markets, and it is now seeking partnerships with leading international distributors
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).